|
|
||||||||
The Journal of Immunology, Vol 147, Issue 8 2483-2492, Copyright © 1991 by American Association of Immunologists
ARTICLES |
N Muthusamy, AR Baluyut and B Subbarao
Department of Microbiology and Immunology, University of Kentucky, Lexington 40536.
The differential effect of cAMP on the regulation of early biochemical and cellular functions mediated through two different receptors on murine B cells are reported here. Surface IgM, the Ag receptor, and Lyb2, a 45-kDa differentiation Ag are concomitantly expressed on mature murine B lymphocytes. Triggering of B cells through these molecules, independently, resulted in inositol 1,4,5-triphosphate (IP3) generation, increase in intracellular Ca2+ levels, and cell enlargement associated with progression of cells from G0 to G1 ultimately resulting in DNA synthesis. Pretreatment of resting B cells with cholera toxin as well as other agents that raise the intracellular cAMP [(cAMP)i] such as forskolin, N6,2'-O-dibutyryl cyclic AMP, and 3-isobutyl-1 methyl xanthine inhibited the Ag receptor but not Lyb2-mediated DNA synthesis. The elevation of (cAMP)i inhibited the surface IgM but not Lyb2- mediated IP3 generation, Ca2+ response, and progression from G0 to G1 phase of the cell cycle. Failure of forskolin or N6,2'-O-dibutyryl cyclic AMP to inhibit Lyb2-mediated responses did not appear to be due to induction of cAMP-specific phosphodiesterase activity. Concentrations of H8 [N-(2-(methylamino)-ethyl)-5-isoquinoline sulfonamide, diHCl] inhibitory to cAMP dependent PKA prevented the inhibitory effect of forskolin on surface IgM-mediated Ca2+ response, suggesting that cAMP exerted its effects through PKA. These findings suggest that distinct PLC-coupled receptors, such as sIgM and Lyb2 molecules in B cells, may use either alternative mechanisms for phosphatidylinositol 4,5-bisphosphate hydrolysis or may use different intermediary transducer molecules that differ in their sensitivity to increased (cAMP)i levels. Thus "cross-talk" among cAMP and phosphatidylinositol signaling pathways was demonstrated for IgM but not Lyb2-mediated B cell activation.
This article has been cited by other articles:
![]() |
T. O. Nashar and J. R. Drake Dynamics of MHC Class II-Activating Signals in Murine Resting B Cells J. Immunol., January 15, 2006; 176(2): 827 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Wu, C. Venkataraman, S. Estus, C. Dong, R. J. Davis, R. A. Flavell, and S. Bondada Positive Signaling Through CD72 Induces Mitogen-Activated Protein Kinase Activation and Synergizes with B Cell Receptor Signals to Induce X-Linked Immunodeficiency B Cell Proliferation J. Immunol., August 1, 2001; 167(3): 1263 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Natarajan, N. C. Sahoo, and K. V. S. Rao Signal Thresholds and Modular Synergy During Expression of Costimulatory Molecules in B Lymphocytes J. Immunol., July 1, 2001; 167(1): 114 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Agren, E. Sverremark, L. Ekman, K. Schon, B. Lowenadler, C. Fernandez, and N. Lycke The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects J. Immunol., June 15, 2000; 164(12): 6276 - 6286. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Venkataraman, N. Muthusamy, S. Muthukkumar, and S. Bondada Activation of Lyn, Blk, and Btk But Not Syk in CD72-Stimulated B Lymphocytes J. Immunol., April 1, 1998; 160(7): 3322 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bikah, J. Carey, J. R. Ciallella, A. Tarakhovsky, and S. Bondada CD5-Mediated Negative Regulation of Antigen Receptor-Induced Growth Signals in B-1 B Cells Science, December 13, 1996; 274(5294): 1906 - 1909. [Abstract] [Full Text] |
||||
![]() |
A.-L. Hsu, T.-T. Ching, G. Sen, D.-S. Wang, S. Bondada, K. S. Authi, and C.-S. Chen Novel Function of Phosphoinositide 3-Kinase in T Cell Ca2+ Signaling. A PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-MEDIATED Ca2+ ENTRY MECHANISM J. Biol. Chem., May 19, 2000; 275(21): 16242 - 16250. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |